Corbion N.V (CRBN) | Financial Analysis & Statements
Corbion N.V. Large-cap Basic Materials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Balance Sheet Metrics
Total Assets
1.4B
Total Liabilities
674.3M
Shareholders Equity
742.6M
Debt to Equity
0.91
Cash Flow Metrics
Revenue & Profitability Trend
Annual Income Flow
2025
Corbion N.V Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.3B | 1.3B | 1.3B | 1.5B | 1.1B |
| Cost of Goods Sold | 937.1M | 976.0M | 958.7M | 1.1B | 805.0M |
| Gross Profit | 330.3M | 312.1M | 305.4M | 324.3M | 265.8M |
| Gross Margin % | 26.1% | 24.2% | 24.2% | 22.2% | 24.8% |
| Operating Expenses | |||||
| Research & Development | 42.8M | 48.0M | 45.6M | 47.2M | 65.8M |
| Selling, General & Administrative | 171.0M | 187.6M | 177.3M | 173.5M | 153.0M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 213.8M | 235.6M | 222.9M | 220.7M | 218.8M |
| Operating Income | 116.5M | 76.5M | 82.5M | 103.6M | 47.0M |
| Operating Margin % | 9.2% | 5.9% | 6.5% | 7.1% | 4.4% |
| Non-Operating Items | |||||
| Interest Income | 4.6M | 5.8M | 6.4M | 3.4M | 2.0M |
| Interest Expense | 15.9M | 22.2M | 34.8M | 17.0M | 13.7M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 94.9M | 62.5M | 45.4M | 116.4M | 86.5M |
| Income Tax | 20.1M | 16.6M | 2.3M | 26.4M | 8.2M |
| Effective Tax Rate % | 21.2% | 26.6% | 5.1% | 22.7% | 9.5% |
| Net Income | 74.8M | 192.2M | 72.9M | 90.0M | 78.3M |
| Net Margin % | 5.9% | 14.9% | 5.8% | 6.2% | 7.3% |
| Key Metrics | |||||
| EBITDA | 196.6M | 171.5M | 164.8M | 200.3M | 129.1M |
| EPS (Basic) | €1.29 | €3.29 | €1.23 | €1.53 | €1.33 |
| EPS (Diluted) | €1.27 | €3.24 | €1.22 | €1.51 | €1.32 |
| Basic Shares Outstanding | 57987740 | 58429164 | 59062628 | 59000000 | 58900000 |
| Diluted Shares Outstanding | 57987740 | 58429164 | 59062628 | 59000000 | 58900000 |
Income Statement Trend
Corbion N.V Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 44.7M | 49.3M | 70.2M | 58.2M | 42.2M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 174.9M | 173.0M | 200.9M | 210.5M | 163.2M |
| Inventory | 241.2M | 258.1M | 262.9M | 331.2M | 230.0M |
| Other Current Assets | - | - | - | - | - |
| Total Current Assets | 580.0M | 513.0M | 579.7M | 654.3M | 504.5M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 75.7M | 71.0M | 72.9M | 82.0M | 69.9M |
| Goodwill | 117.8M | 129.1M | 237.7M | 247.1M | 235.6M |
| Intangible Assets | 60.4M | 68.9M | 75.1M | 80.1M | 80.2M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | - | - | - | - | - |
| Total Non-Current Assets | 836.9M | 1.0B | 1.1B | 1.1B | 836.6M |
| Total Assets | 1.4B | 1.5B | 1.7B | 1.7B | 1.3B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 109.3M | 105.3M | 104.3M | 148.3M | 128.0M |
| Short-term Debt | 99.0M | 201.3M | 368.5M | 322.0M | 84.6M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 96.4M | 15.4M | 8.8M | 3.5M | - |
| Total Current Liabilities | 306.6M | 438.0M | 588.3M | 592.7M | 321.0M |
| Non-Current Liabilities | |||||
| Long-term Debt | 347.6M | 307.9M | 417.0M | 437.2M | 418.6M |
| Deferred Tax Liabilities | 14.6M | 16.6M | 28.3M | 30.0M | 25.4M |
| Other Non-Current Liabilities | 300.0K | 3.9M | 12.8M | 15.8M | 16.9M |
| Total Non-Current Liabilities | 367.7M | 335.8M | 462.3M | 487.0M | 466.0M |
| Total Liabilities | 674.3M | 773.8M | 1.1B | 1.1B | 787.0M |
| Equity | |||||
| Common Stock | 14.8M | 14.8M | 14.8M | 14.8M | 14.8M |
| Retained Earnings | 706.6M | 675.8M | 540.6M | 493.8M | 430.2M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 742.6M | 772.5M | 636.2M | 625.7M | 554.1M |
| Key Metrics | |||||
| Total Debt | 446.6M | 509.2M | 785.5M | 759.2M | 503.2M |
| Working Capital | 273.4M | 75.0M | -8.6M | 61.6M | 183.5M |
Balance Sheet Composition
Corbion N.V Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 116.5M | 281.8M | 117.2M | 110.8M | 82.0M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | 5.2M | 4.7M | 4.1M | 4.8M | 3.5M |
| Working Capital Changes | -30.2M | 32.0M | 60.1M | -125.6M | -105.5M |
| Operating Cash Flow | 91.5M | 318.5M | 181.4M | -10.0M | -31.8M |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Acquisitions | - | - | - | - | 11.1M |
| Investment Purchases | -1.9M | -1.6M | -2.1M | -1.0M | -700.0K |
| Investment Sales | - | - | - | 12.7M | 6.2M |
| Investing Cash Flow | -1.9M | 250.2M | -2.1M | 11.7M | 16.6M |
| Financing Activities | |||||
| Share Repurchases | -10.0M | -20.0M | - | - | - |
| Dividends Paid | -37.2M | -41.9M | -33.1M | -33.0M | -33.0M |
| Debt Issuance | 2.0M | 0 | 46.0M | 236.0M | 132.0M |
| Debt Repayment | -35.3M | -296.2M | -4.8M | -2.7M | -2.9M |
| Financing Cash Flow | -80.5M | -358.1M | 8.1M | 185.4M | 96.1M |
| Free Cash Flow | 92.7M | 99.9M | 16.1M | -196.8M | -126.3M |
| Net Change in Cash | 9.1M | 210.6M | 187.4M | 187.1M | 80.9M |
Cash Flow Trend
Corbion N.V Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
14.56
Forward P/E
11.57
Price to Book
1.43
Price to Sales
0.84
PEG Ratio
11.57
Profitability Ratios
Profit Margin
5.90%
Operating Margin
8.73%
Return on Equity
9.87%
Return on Assets
5.00%
Financial Health
Current Ratio
1.89
Debt to Equity
60.14
Beta
0.94
Per Share Data
EPS (TTM)
€1.27
Book Value per Share
€12.89
Revenue per Share
€21.86
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| CRBN | 1.1B | 14.56 | 1.43 | 9.87% | 5.90% | 60.14 |
| DSM-Firmenich AG | 16.2B | 53.42 | 0.89 | 1.66% | -11.97% | 28.64 |
| Akzo Nobel N.V | 9.0B | 14.47 | 1.97 | 13.95% | 6.25% | 100.83 |
| IMCD N.V | 5.7B | 26.18 | 2.79 | 10.22% | 4.53% | 87.66 |
| OCI N.V | 766.7M | 27.05 | 0.84 | -20.70% | 16.92% | 14.45 |
Financial data is updated regularly. All figures are in the company's reporting currency.